Next Article in Journal
A Non-Derivatized Assay for the Simultaneous Detection of Amino Acids, Acylcarnitines, Succinylacetone, Creatine, and Guanidinoacetic Acid in Dried Blood Spots via Tandem Mass Spectrometry
Next Article in Special Issue
Newborn Screening for X-Linked Adrenoleukodystrophy
Previous Article in Journal
Critical Newborn Screens in Double Heterozygotes of Inborn Errors of Metabolism—A Clinical Report and Recommendations
Previous Article in Special Issue
The Further Adventures of Newborn Screening for Biotinidase Deficiency: Where It Is at and What We Still Need to Know
Article Menu

Export Article

Open AccessArticle
Int. J. Neonatal Screen. 2016, 2(4), 14; doi:10.3390/ijns2040014

A Life in Newborn Screening

1
Division of Genetics and Genomics, Boston Children’s Hospital, Boston, MA 02115, USA
2
Department of Pediatrics Harvard Medical School, Boston, MA 02115, USA
Academic Editor: Peter C. J. I. Schielen
Received: 22 September 2016 / Revised: 4 November 2016 / Accepted: 10 November 2016 / Published: 24 November 2016
(This article belongs to the Special Issue Newborn Screening-Past, Present and Future)
View Full-Text   |   Download PDF [838 KB, uploaded 24 November 2016]   |  

Abstract

Newborn screening has revolutionized the diagnosis of many disorders, notably metabolic disorders. Whereas, formerly, a clinical presentation of developmental delay or other features led to the diagnosis, usually too late for optimal treatment, today it is an abnormal finding in newborn screening which leads to the diagnosis and presymptomatic preventative therapy. It is my good fortune to have been involved in newborn screening for virtually all of my 50 years in metabolic disorders—the first 31 years with direct involvement. I have been part of the expansion of newborn screening from the time of the original Guthrie bacterial assays to the addition of tandem mass spectrometry. Newborn screening continues to be a central part of my professional life. This article describes my journey in newborn screening as a metabolic physician and the hallmarks of this journey within the rich history of newborn screening. View Full-Text
Keywords: newborn screening; expanded screening; my life; medical community; phenylketonuria; PKU; maternal newborn screening; expanded screening; my life; medical community; phenylketonuria; PKU; maternal
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Levy, H.L. A Life in Newborn Screening. Int. J. Neonatal Screen. 2016, 2, 14.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Neonatal Screen. EISSN 2409-515X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top